In 2005, it was estimated that the United States spent $19.7 billion on 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) drug therapy. Strategies such as reference-based pricing […]
Pramik is industry veteran in healthcare analytics & medical management IT and will be great addition to the already experienced RxResults management team.